Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-16

Clinical Trial Update: Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial investigates neurofeedback therapy as a treatment for depression in Phase 1 and Phase 2 and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neurofeedback Therapy

Snippet

Sponsor: UNB Sumiyoshi Jinja Mae Clinic | Conditions: Depression | Phase 1, Phase 2 | Status: RECRUITING